285 related articles for article (PubMed ID: 11707392)
1. Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex.
Eklof Spink K; Fridman SG; Weis WI
EMBO J; 2001 Nov; 20(22):6203-12. PubMed ID: 11707392
[TBL] [Abstract][Full Text] [Related]
2. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin.
Huber AH; Weis WI
Cell; 2001 May; 105(3):391-402. PubMed ID: 11348595
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function.
Xing Y; Clements WK; Le Trong I; Hinds TR; Stenkamp R; Kimelman D; Xu W
Mol Cell; 2004 Aug; 15(4):523-33. PubMed ID: 15327769
[TBL] [Abstract][Full Text] [Related]
4. Structure of a human Tcf4-beta-catenin complex.
Poy F; Lepourcelet M; Shivdasani RA; Eck MJ
Nat Struct Biol; 2001 Dec; 8(12):1053-7. PubMed ID: 11713476
[TBL] [Abstract][Full Text] [Related]
5. Differences between the interaction of beta-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein.
Tickenbrock L; Kössmeier K; Rehmann H; Herrmann C; Müller O
J Mol Biol; 2003 Mar; 327(2):359-67. PubMed ID: 12628243
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of the armadillo repeat region of beta-catenin.
Huber AH; Nelson WJ; Weis WI
Cell; 1997 Sep; 90(5):871-82. PubMed ID: 9298899
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.
Xing Y; Clements WK; Kimelman D; Xu W
Genes Dev; 2003 Nov; 17(22):2753-64. PubMed ID: 14600025
[TBL] [Abstract][Full Text] [Related]
8. A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo.
Hayashi S; Rubinfeld B; Souza B; Polakis P; Wieschaus E; Levine AJ
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):242-7. PubMed ID: 8990193
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a beta-catenin/Tcf complex.
Graham TA; Weaver C; Mao F; Kimelman D; Xu W
Cell; 2000 Dec; 103(6):885-96. PubMed ID: 11136974
[TBL] [Abstract][Full Text] [Related]
10. Identification of Tcf4 residues involved in high-affinity beta-catenin binding.
Omer CA; Miller PJ; Diehl RE; Kral AM
Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941
[TBL] [Abstract][Full Text] [Related]
11. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
12. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
[TBL] [Abstract][Full Text] [Related]
14. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF.
Hamada F; Bienz M
Dev Cell; 2004 Nov; 7(5):677-85. PubMed ID: 15525529
[TBL] [Abstract][Full Text] [Related]
15. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
Schneikert J; Ruppert JG; Behrens J; Wenzel EM
PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
[TBL] [Abstract][Full Text] [Related]
16. Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.
Schneikert J; Vijaya Chandra SH; Ruppert JG; Ray S; Wenzel EM; Behrens J
PLoS One; 2013; 8(7):e68072. PubMed ID: 23840886
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of E-APC, a novel Drosophila homologue of the tumour suppressor APC.
Hamada F; Murata Y; Nishida A; Fujita F; Tomoyasu Y; Nakamura M; Toyoshima K; Tabata T; Ueno N; Akiyama T
Genes Cells; 1999 Aug; 4(8):465-74. PubMed ID: 10526234
[TBL] [Abstract][Full Text] [Related]
18. APC 3 x 15 beta-catenin-binding domain potentiates beta-catenin association to TBP and upregulates TCF-4 transcriptional activity.
Roura S; Martínez D; Piedra J; Miravet S; García de Herreros A; Duñach M
Biochem Biophys Res Commun; 2003 Oct; 309(4):830-5. PubMed ID: 13679048
[TBL] [Abstract][Full Text] [Related]
19. Systematic peptide array-based delineation of the differential beta-catenin interaction with Tcf4, E-cadherin, and adenomatous polyposis coli.
Gail R; Frank R; Wittinghofer A
J Biol Chem; 2005 Feb; 280(8):7107-17. PubMed ID: 15591320
[TBL] [Abstract][Full Text] [Related]
20. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway.
Xiao JH; Ghosn C; Hinchman C; Forbes C; Wang J; Snider N; Cordrey A; Zhao Y; Chandraratna RA
J Biol Chem; 2003 Aug; 278(32):29954-62. PubMed ID: 12771132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
